Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
HANSOH PHARMA Issues $4.68B Zero Coupon Convertible Bonds
Recommend 2 Positive 4 Negative 0 |
||||
|
||||
|
HANSOH PHARMA (03692.HK) announced a proposal to issue zero coupon convertible bonds worth $4.68 billion, maturing in 2033. The initial Conversion Price per share is set at $57.39, representing a premium of approx. 42.62% over yesterday's (26th) closing price of $40.24. The bonds will be fully convertible into 81.5473 million shares, representing approx. 1.33% of its enlarged share capital. The net proceeds from the bonds are estimated to be approx. $4.64 billion, with approx. 65% on drug R&D and in-licensing, including the R&D of innovative drugs for oncology, central nervous system, metabolic and autoimmune diseases, and in-licensing projects for innovative drugs and innovative R&D platforms; approx. 25% on the construction of new R&D centers and production lines, and the upgrade of existing R&D and production facilities, including the construction of innovative drug R&D centers and laboratories, the construction of new production lines and the upgrading of existing R&D laboratories and production workshops; and approx. 10% for working capital and other general corporate purposes. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
